Experiment 723333

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED

Compounds isolated

RESVERATROL

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.VS.12-O-TETRADECANOYLPHORBOL-13-ACETATE(TPA)-INDUCED CARCINOGENESIS.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeEXTERNAL
OrganismCassia quinquangulata (FABACEAE)
CitationPEZZUTO,JM:. (1998). CANCER CHEMOPREVENTATIVE COMPOSITION AND METHOD.. ()
Amount utilized
Compound isolated
Dose amount1.0 MICROMOLS
Number8
Qualitative resultACTIVE
AnimalMOUSE
Dose expressionDOSE
GenderFEMALE